• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于患者残疾状况的 COVID-19 临床结局:一项回顾性队列研究。

COVID-19 clinical outcomes by patient disability status: A retrospective cohort study.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Cochlear Center for Hearing and Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Johns Hopkins Disability Health Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Cochlear Center for Hearing and Public Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Disabil Health J. 2023 Apr;16(2):101441. doi: 10.1016/j.dhjo.2023.101441. Epub 2023 Jan 12.

DOI:10.1016/j.dhjo.2023.101441
PMID:36764842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9834120/
Abstract

BACKGROUND

People with disabilities might experience worse clinical outcomes of SARS-CoV-2 infection, but evidence is limited.

OBJECTIVE

To investigate if people with disabilities requiring assistance are more likely to experience severe COVID-19 or death.

METHODS

Data from the Johns Hopkins COVID-19 Precision Medicine Analytics Platform Registry (JH-CROWN) included 6494 adult patients diagnosed with COVID-19 and admitted between March 4, 2020-October 29, 2021. Severe COVID-19 and death were defined using the occurrence and timing of clinical events. Assistive needs due to disabilities were reported by patients or their proxies upon admission. Multivariable-adjusted Cox proportional hazards models were used to examine the associations between disability status and severe COVID-19 or death. Primary models adjusted for demographics and secondary models additionally adjusted for clinical covariates.

RESULTS

In this clinical cohort (47-73 years, 49% female, 39% Black), patients with disabilities requiring assistance had 1.35 times (95% confidence interval [CI]:1.01, 1.81) the hazard of severe COVID-19 among patients <65 years, but not among those ≥65 years, equating to an additional 17.5 severe COVID-19 cases (95% CI:7.7, 28.2) per 100 patients. A lower risk of mortality was found among patients <65 years, but this finding was not robust due to the small number of deaths.

CONCLUSIONS

People with disabilities requiring assistance aged <65 years are more likely to develop severe COVID-19. Although our study is limited by using a medical model of disability, these analyses intend to further our understanding of COVID-19 outcomes among people with disabilities. Also, standardized disability data collection within electronic health records is needed.

摘要

背景

残疾人士可能经历更差的 SARS-CoV-2 感染临床结局,但证据有限。

目的

调查是否需要辅助的残疾人士更可能经历严重 COVID-19 或死亡。

方法

来自约翰霍普金斯 COVID-19 精准医学分析平台注册(JH-CROWN)的数据包括 6494 名成年 COVID-19 患者,诊断和住院时间为 2020 年 3 月 4 日至 2021 年 10 月 29 日。严重 COVID-19 和死亡通过临床事件的发生和时间定义。残疾导致的辅助需求由患者或其代理人在入院时报告。使用多变量调整 Cox 比例风险模型检查残疾状况与严重 COVID-19 或死亡之间的关联。初级模型调整了人口统计学因素,次级模型另外调整了临床协变量。

结果

在这个临床队列中(年龄 47-73 岁,49%女性,39%黑人),<65 岁需要辅助的残疾患者严重 COVID-19 的风险是<65 岁无残疾患者的 1.35 倍(95%CI:1.01,1.81),相当于每 100 名患者增加 17.5 例严重 COVID-19(95%CI:7.7,28.2)。在<65 岁的患者中发现死亡率较低,但由于死亡人数较少,该发现不稳健。

结论

<65 岁需要辅助的残疾人士更可能发生严重 COVID-19。尽管我们的研究受到残疾医学模型的限制,但这些分析旨在进一步了解残疾人士的 COVID-19 结局。还需要在电子健康记录中进行标准化的残疾数据收集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f95/9834120/ddf4ac1d7429/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f95/9834120/14a5bf1b21fd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f95/9834120/ddf4ac1d7429/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f95/9834120/14a5bf1b21fd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f95/9834120/ddf4ac1d7429/gr2_lrg.jpg

相似文献

1
COVID-19 clinical outcomes by patient disability status: A retrospective cohort study.基于患者残疾状况的 COVID-19 临床结局:一项回顾性队列研究。
Disabil Health J. 2023 Apr;16(2):101441. doi: 10.1016/j.dhjo.2023.101441. Epub 2023 Jan 12.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study.COVID-19 住院患者有无残疾的结局:一项回顾性队列研究。
CMAJ. 2022 Jan 31;194(4):E112-E121. doi: 10.1503/cmaj.211277.
4
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.学习障碍人群因新冠病毒感染住院和死亡的风险:利用 OpenSAFELY 平台开展的基于人群的队列研究。
BMJ. 2021 Jul 14;374:n1592. doi: 10.1136/bmj.n1592.
5
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.纽约市一家城市医疗中心的 COVID-19 患者种族与合并症及生存率的关系。
JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795.
6
Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study.在加拿大安大略省,有近期无家可归史的人群中 COVID-19 的检测、感染和并发症发生率:一项回顾性队列研究。
CMAJ Open. 2021 Jan 11;9(1):E1-E9. doi: 10.9778/cmajo.20200287. Print 2021 Jan-Mar.
7
COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study.印第安纳州成年癌症患者的COVID-19诊断与死亡风险:回顾性队列研究
JMIR Cancer. 2022 Oct 6;8(4):e35310. doi: 10.2196/35310.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study.英格兰 COVID-19 大流行前两波期间自我报告残疾状况导致的 COVID-19 死亡:一项回顾性、基于人群的队列研究。
Lancet Public Health. 2021 Nov;6(11):e817-e825. doi: 10.1016/S2468-2667(21)00206-1. Epub 2021 Oct 7.
10
Post-COVID conditions and healthcare utilization among adults with and without disabilities-2021 Porter Novelli FallStyles survey.新冠后状况及残疾与非残疾成年人的医疗保健利用情况——2021 年波特诺埃利秋季风尚调查。
Disabil Health J. 2023 Apr;16(2):101436. doi: 10.1016/j.dhjo.2022.101436. Epub 2022 Dec 19.

引用本文的文献

1
"I'm in Hell …": Experiences of Unmet Health Care Needs Among People with Pre-Existing Disability and Long COVID.“我身处地狱……”:残疾老人和新冠长期症状患者未满足的医疗需求体验
J Health Care Poor Underserved. 2025;36(2):572-589. doi: 10.1353/hpu.2025.a959114.
2
Age-Stratified Risk of Severe COVID-19 for People With Disabilities in Korea: Nationwide Study Considering Disability Type.韩国残疾人士中按年龄分层的重症新冠风险:考虑残疾类型的全国性研究
J Korean Med Sci. 2025 Feb 24;40(7):e37. doi: 10.3346/jkms.2025.40.e37.
3
Social Determinants of Health Affect Psychological Distress among People with Disabilities.

本文引用的文献

1
COVID-19 mortality burden and comorbidity patterns among decedents with and without intellectual and developmental disability in the US.美国有和没有智力与发育障碍的死者中新冠病毒疾病的死亡负担及共病模式
Disabil Health J. 2022 Oct;15(4):101376. doi: 10.1016/j.dhjo.2022.101376. Epub 2022 Sep 7.
2
COVID-19 Cases and Hospitalizations Among Medicare Beneficiaries With and Without Disabilities - United States, January 1, 2020-November 20, 2021.2020 年 1 月 1 日-2021 年 11 月 20 日期间,美国医疗保险受益人与非残疾受益人中的 COVID-19 病例和住院情况。
MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):791-796. doi: 10.15585/mmwr.mm7124a3.
3
健康的社会决定因素会影响残疾人群的心理困扰。
Int J Environ Res Public Health. 2024 Oct 15;21(10):1359. doi: 10.3390/ijerph21101359.
4
Mortality trends in people with disabilities before and during the COVID-19 pandemic in South Korea, 2017-2022.2017-2022 年韩国 COVID-19 大流行前后残疾人群的死亡率趋势。
Front Public Health. 2024 Jul 25;12:1414515. doi: 10.3389/fpubh.2024.1414515. eCollection 2024.
5
The mortality experience of disabled persons in the United States during the COVID-19 pandemic.美国残疾人在新冠疫情期间的死亡情况。
Health Aff Sch. 2023 Dec 8;2(1):qxad082. doi: 10.1093/haschl/qxad082. eCollection 2024 Jan.
Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study.
COVID-19 住院患者有无残疾的结局:一项回顾性队列研究。
CMAJ. 2022 Jan 31;194(4):E112-E121. doi: 10.1503/cmaj.211277.
4
National Prevalence of Disability and Disability Types Among Adults in the US, 2019.美国成年人 2019 年残疾状况和残疾类型的全国流行率。
JAMA Netw Open. 2021 Oct 1;4(10):e2130358. doi: 10.1001/jamanetworkopen.2021.30358.
5
Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study.英格兰 COVID-19 大流行前两波期间自我报告残疾状况导致的 COVID-19 死亡:一项回顾性、基于人群的队列研究。
Lancet Public Health. 2021 Nov;6(11):e817-e825. doi: 10.1016/S2468-2667(21)00206-1. Epub 2021 Oct 7.
6
Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK.了解与普通人群相比,因 COVID-19 住院的智力残疾患者的结局不平等情况:英国一项匹配队列研究。
BMJ Open. 2021 Oct 4;11(10):e052482. doi: 10.1136/bmjopen-2021-052482.
7
"Do-not-resuscitate (DNR)" status determines mortality in patients with COVID-19.“不复苏”(DNR)状态决定 COVID-19 患者的死亡率。
Clin Dermatol. 2021 May-Jun;39(3):510-516. doi: 10.1016/j.clindermatol.2020.11.013. Epub 2020 Nov 28.
8
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.学习障碍人群因新冠病毒感染住院和死亡的风险:利用 OpenSAFELY 平台开展的基于人群的队列研究。
BMJ. 2021 Jul 14;374:n1592. doi: 10.1136/bmj.n1592.
9
COVID-19 case-fatality disparities among people with intellectual and developmental disabilities: Evidence from 12 US jurisdictions.12 个美国管辖区内智力和发育障碍人群的 COVID-19 病死率差异:证据。
Disabil Health J. 2021 Oct;14(4):101116. doi: 10.1016/j.dhjo.2021.101116. Epub 2021 May 14.
10
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.COVID-19 重症和死亡的人群风险因素:一项全球系统回顾和荟萃分析。
PLoS One. 2021 Mar 4;16(3):e0247461. doi: 10.1371/journal.pone.0247461. eCollection 2021.